Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $6.50 (16.91% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/20/2014ZacksUpgradeNeutral -> Outperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2014Deutsche BankUpgradeNeutralViewTweet This Rating  Share This Rating on StockTwits
5/1/2014JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$7.00ViewTweet This Rating  Share This Rating on StockTwits
9/26/2013Maxim GroupBoost Price TargetBuy$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2013Maxim GroupBoost Price TargetBuy$3.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
10/26/2012Maxim GroupUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/20/2012 forward)
Discuss Pacific Biosciences of California